As of 09-Oct-2026
4QFY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 2.2B
12MFY26: Rs 9.5B (+62.1%)
Net profit
Rs 167M
12MFY26: Rs 633M (+41.3%)
EPS
Rs 1.89
12MFY26: Rs 7.16 (+29.0%)
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
61.83M (70.00%)
Free Float shares
26.50M (30.00%)
Market Cap
10.97B
#11 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to BFBIO by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| CPHL Citi Pharma | 64.76 | Rs 14.6B | 19.1x | 5.5% |
| FEROZ Ferozsons Laboratories | 328.26 | Rs 14.6B | 15.1x | 1.2% |
| MACTER Macter International | 249.15 | Rs 11.4B | 16.3x | 0.8% |
| BFBIO BF Biosciences (this stock) | 124.18 | Rs 10.9B | 17.3x | - |
| OTSU Otsuka Pakistan | 359.78 | Rs 4.2B | 9.0x | - |
| IBLHL IBL HealthCare | 41.12 | Rs 4B | 18.6x | - |
| LIVEN Liven Pharma | 30.37 | Rs 3.4B | - | - |
BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products. BF Biosciences Limited (BFBIO) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is marked Shariah-compliant on the KMI screening.
BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.
BF Biosciences Limited (BFBIO) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare BFBIO with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
